Full Text View
Tabular View
No Study Results Posted
Related Studies
Amlodipine Plus Botulinum Toxin for Focal Dystonia
This study has been completed.
Study NCT00015457   Information provided by National Institutes of Health Clinical Center (CC)
First Received: April 18, 2001   Last Updated: April 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Focal Dystonia
Additional conditions recognized in this trial
Dystonia
Dystonic Disorders
More general conditions related to this trial
Central Nervous System Diseases
Dyskinesias
Movement Disorders
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Amlodipine plus Botulinum toxin
Additional drug interventions recognized in this trial
Amlodipine
Botulinum Toxins
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services